期刊
AMINO ACIDS
卷 23, 期 1-3, 页码 57-63出版社
SPRINGER WIEN
DOI: 10.1007/s00726-001-0110-x
关键词
L-DOPA; Parkinson's disease; reactive oxygen species
资金
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS039272] Funding Source: NIH RePORTER
- NINDS NIH HHS [NS39272] Funding Source: Medline
Despite its being the most efficacious drug for symptom reversal in Parkinson's disease (PD), there is concern that chronic levodopa (L-DOPA) treatment may be detrimental. In this paper we review the potential for L-DOPA to 1) autoxidize from a catechol to a quinone, and 2) generate other reactive oxygen species (ROS). Overt toxicity and neuroprotective effects of L-DOPA, both in vivo and in vitro, are described in the context of whether L-DOPA may accelerate or delay progression of human Parkinson's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据